A new age of medicine is underway, and we’re only just beginning to grapple with the implications. The first U.S. gene therapy, for a rare form of vision loss, is now on the market. In 2017, the FDA also approved the first two CAR-T cell therapies for cancer, the first cancer drug based on a […]
Original Article: Paying for Gene Therapy, CRISPR in People, RNAi at “What’s Hot” on May 16